MolNFT v1 · #74535 · protein

Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.

3OZL: “Crystal structure of human transthyretin variant A25T in complex with flufenamic acid.”. X-ray diffraction, 1 ligand (FLF), 3 pockets (best druggability 0.36). MolNFT v1 #74535 on GenesisL1: 3D structure, binding sites and pockets…

PDB: 3OZL
Type: protein
Length: 231 residues
Chains: 2
Method: x-ray diffraction
Collection: MolNFT v1 / PDB
Contract: 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner: 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule: Transthyretin
UniProt: P02766
Ligands: FLF
Pockets: 3 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

Chain	Molecule	Type	Residues	Secondary structure	UniProt
A	Transthyretin	protein	116	6% helix, 51% strand	P02766
B	Transthyretin	protein	115	6% helix, 51% strand	P02766

Ligands and binding sites

FLF · 2-[[3-(trifluoromethyl)phenyl]amino] benzoic acid · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

Pocket	Volume (Å³)	Druggability	Buriedness	Lining residues	Inside
1	79	0.36	0.76	16	empty
2	85	0.34	0.75	15	empty
3	74	0.31	0.74	18	empty

Interfaces

1 interface between chains.

A–B · 913 Å² buried · 19 hydrogen bonds · protein-protein

Compared structures

3OZL · Crystal structure of human transthyretin variant A25T in complex with flufenamic acid. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
Every structure of UniProt P02766
Elsewhere: RCSB PDB 3OZL · PDBe 3OZL · UniProt P02766

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.